openPR Logo
Press release

At A CAGR 22.5%, NGS-based RNA Sequencing Market Is Expected To Reach Over Us$ 21.3 Billion By 2031 | Global Insight Services

11-15-2023 07:42 AM CET | Health & Medicine

Press release from: Global Insight Services

/ PR Agency: Global Insight Services
At A CAGR 22.5%, NGS-based RNA Sequencing Market Is Expected

The Next-Generation Sequencing (NGS)-based RNA sequencing market encompasses a transformative segment within genomics, offering advanced methodologies to analyze and understand gene expression patterns, splice variants, and RNA modifications. This market has experienced significant growth owing to the increasing demand for high-throughput RNA sequencing technologies in various research domains, including molecular biology, clinical diagnostics, and drug discovery. NGS-based RNA sequencing enables comprehensive analysis of transcriptomes, allowing researchers to uncover intricate details about gene regulation, RNA splicing, and identifying novel transcripts and non-coding RNAs.

Request for Free Sample @ https://www.globalinsightservices.com/request-sample/GIS10519

Technological advancements in sequencing platforms, bioinformatics tools, and library preparation kits have improved sequencing accuracy, reduced costs, and facilitated the analysis of complex transcriptomic data. Moreover, the expanding applications of RNA sequencing in studying diseases, precision medicine, and biomarker discovery drive the continual evolution and adoption of NGS-based RNA sequencing technologies, providing insights into the intricacies of gene expression and RNA biology that are fundamental to advancing various scientific and clinical endeavors.

Key Trends

A prominent trend shaping the NGS-based RNA sequencing market is the convergence of RNA sequencing with single-cell analysis techniques. This trend involves the integration of high-throughput RNA sequencing with single-cell resolution, allowing researchers to explore gene expression profiles at a cellular level. Advancements in microfluidics, sample preparation methodologies, and bioinformatics tools enable the profiling of individual cells' transcriptomes, offering insights into cellular heterogeneity, developmental biology, and disease mechanisms.

Read Full Research Report @ https://www.globalinsightservices.com/reports/ngs-based-rna-sequencing-market/

Key Drivers

An essential driver propelling the NGS-based RNA sequencing market is the escalating demand for high-throughput, cost-effective, and precise methods to analyze gene expression patterns and RNA biology. The widespread adoption of RNA sequencing technologies is driven by their capability to provide comprehensive insights into transcriptomes, uncovering crucial information about gene regulation, alternative splicing, and RNA modifications. Additionally, the increasing focus on precision medicine, biomarker discovery, and understanding complex diseases like cancer drives the need for sophisticated RNA sequencing approaches that can analyze vast amounts of RNA data with accuracy and efficiency.

Buy Now@ https://www.globalinsightservices.com/checkout/single_user/GIS10519

Market Segmentation : NGS-based RNA Sequencing Market

NGS-based RNA Sequencing Market By Product & Services : Sample Preparation, Platforms & Consumables, Services, Data Analysis

NGS-based RNA Sequencing Market By Technology : Single-Molecule Real-Time Sequencing, Ion Semiconductor
Sequencing, Sequencing By Synthesis, Nanopore Sequencing

NGS-based RNA Sequencing Market By Application : De novo, Epigenetics, Small RNA

NGS-based RNA Sequencing Market By Region : North America : US, Canada, Mexico, Europe : The UK, Germany, France, Italy, Spain, Netherlands, Switzerland, Asia-Pacific : China, India, Japan, South Korea, Australia, Singapore, Indonesia, Rest of Asia-Pacific, Rest of the World : Latin America, Middle East, Africa

Key Players :

Agilent Technologies Inc.
Illumina inc.
BGI Group
Eurofins Scientific SE
Genewiz, Inc.
F. Hoffman- La Roche AG
Thermo Fisher Scientific Inc.
Zymo Research Corporation
Psomagen Inc.
Hamilton Company, Qiagen N.V.
Furuno Electric Co. Ltd.

Request for Customization @https://www.globalinsightservices.com/request-customization/GIS10519

With Global Insight Services, you receive :

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

Contact Us :

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 15998
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services :

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release At A CAGR 22.5%, NGS-based RNA Sequencing Market Is Expected To Reach Over Us$ 21.3 Billion By 2031 | Global Insight Services here

News-ID: 3287916 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for RNA

CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes. CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032. This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - • 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate? • The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%. • Expected exponential
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032. The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may